Development of D-α-Tocopherol Polyethylene Glycol 1000 Succinate Fabricated Nanostructural Lipid Carrier of Sorafenib Tosylate for Metastatic Colorectal Targeting Application: Stability, Physical Characterization, Cytotoxicity, and Apoptotic Studies...

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Nov 17

PMID 36387097

Authors

Sankha Bhattacharya

Satyam Sharma

Bhupendra G Prajapati

Affiliations

Soon will be listed here.

Abstract

The study aimed to create D-α-Tocopherol polyethylene glycol 1000 succinate (TPGS) nanostructured lipid carriers (NLC) of sorafenib tosylate (ST) as lymphatic delivery systems (LDDS) to fight Metastatic colorectal cancer. Initially, ST-SLN, ST-NLC, and ST-LNE were formulated considering oleic acid (OA), glycerol monolinoleate (GMO), glycerol monolinoleate (GML) as solid lipid and further characterised, and tested for stability. The most stable ST-NLC was fabricated with TPGS to produce ST-TPGS-NLC and evaluated by performing drug profiling, cytotoxicity, and apoptotic studies against human female colorectal adenocarcinoma cell lines (SW48 Cells PTEN). Stability studies on three lipidic nanoparticles (ST-SLN, ST-NLC, ST-LEN) showed particle size, polydispersity index, and zeta potential ranging from 165 nm to 298 nm, 0.125 to 0.288, and -31 mV to -16 mV. At 1600 minutes, more than 80% of ST-NLC1 was released, confirming the sustained release pattern of the formulation. ST-NLC and ST-TPGS-NLC have entrapment efficiencies above 50%. Pure ST's IC50 at 72 hr was 3.45 µg/mL, while 1.56 µg/mL was for ST-TPGS-NLC. The ST-TPGS-NLC reduced the number of livings SW48 Cells PTEN from 91% to 5%, compared to 75% to 8% of pure ST. The ST-TPGS-NLC is a promising LDDS for delivering ST for metastatic colorectal cancer.

References

Das S, Lee S, Chia V, Chow P, Macbeath C, Liu Y . Development of microemulsion based topical ivermectin formulations: Pre-formulation and formulation studies. Colloids Surf B Biointerfaces. 2020; 189:110823. DOI: 10.1016/j.colsurfb.2020.110823. View

Hage C, Hoves S, Strauss L, Bissinger S, Prinz Y, Poschinger T . Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell-Mediated Cytotoxicity Against Hepatocellular Carcinoma. Hepatology. 2019; 70(4):1280-1297. DOI: 10.1002/hep.30666. View

Fu D, Zhou J, Xu S, Tu J, Cai Y, Liu J . Smilax glabra Roxb. flavonoids protect against pathological cardiac hypertrophy by inhibiting the Raf/MEK/ERK pathway: In vivo and in vitro studies. J Ethnopharmacol. 2022; 292:115213. DOI: 10.1016/j.jep.2022.115213. View

Kato S, Yoshiba S, Mori S, Kodama T . Optimization of the delivery of molecules into lymph nodes using a lymphatic drug delivery system with ultrasound. Int J Pharm. 2021; 597:120324. DOI: 10.1016/j.ijpharm.2021.120324. View

Hu X, Chen Q, Guo H, Li K, Fu B, Chen Y . Identification of Target PTEN-Based miR-425 and miR-576 as Potential Diagnostic and Immunotherapeutic Biomarkers of Colorectal Cancer With Liver Metastasis. Front Oncol. 2021; 11:657984. PMC: 8418231. DOI: 10.3389/fonc.2021.657984. View

Lam A, Lee J, Merchant S, Jensen C, Sedki M, Corley D . Biopsy of Non-tumor Sites After Biopsy of a Colorectal Cancer is not Associated With Metachronous Cancers: A Case-control Study. Clin Gastroenterol Hepatol. 2022; 21(2):487-496.e3. PMC: 9699896. DOI: 10.1016/j.cgh.2022.05.006. View

Wong A, Ye M, Ulmschneider M, Searson P . Quantitative Analysis of the Enhanced Permeation and Retention (EPR) Effect. PLoS One. 2015; 10(5):e0123461. PMC: 4418820. DOI: 10.1371/journal.pone.0123461. View

Holmback J, Rinwa V, Johansson J, Hakansson J, Rinwa P, Carlsson A . Preclinical development of sodium fusidate antibiotic cutaneous spray based on water-free lipid formulation system. Eur J Pharm Sci. 2022; 176:106250. DOI: 10.1016/j.ejps.2022.106250. View

Amis T, Renukuntla J, Bolla P, Clark B . Selection of Cryoprotectant in Lyophilization of Progesterone-Loaded Stearic Acid Solid Lipid Nanoparticles. Pharmaceutics. 2020; 12(9). PMC: 7560102. DOI: 10.3390/pharmaceutics12090892. View

10.

Moreira L, Chagas A, Ames-Sibin A, Pateis V, Goncalves O, Silva-Comar F . Alpha-tocopherol-loaded polycaprolactone nanoparticles improve the inflammation and systemic oxidative stress of arthritic rats. J Tradit Complement Med. 2022; 12(4):414-425. PMC: 9209870. DOI: 10.1016/j.jtcme.2021.12.003. View

11.

Pi C, Zhao W, Zeng M, Yuan J, Shen H, Li K . Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo. Drug Deliv. 2022; 29(1):1878-1891. PMC: 9246235. DOI: 10.1080/10717544.2022.2086938. View

12.

Taghipour Y, Zarebkohan A, Salehi R, Rahimi F, Torchilin V, Hamblin M . An update on dual targeting strategy for cancer treatment. J Control Release. 2022; 349:67-96. DOI: 10.1016/j.jconrel.2022.06.044. View

13.

Li H, Yu Y, Liu Y, Luo Z, Law B, Zheng Y . Ursolic acid enhances the antitumor effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer. Pharmacol Res. 2022; 182:106306. DOI: 10.1016/j.phrs.2022.106306. View

14.

Zhang S, Wang Y, Cao Y, Wu J, Zhang Z, Ren H . Inhibition of the PINK1-Parkin Pathway Enhances the Lethality of Sorafenib and Regorafenib in Hepatocellular Carcinoma. Front Pharmacol. 2022; 13:851832. PMC: 8967359. DOI: 10.3389/fphar.2022.851832. View

15.

Parvez S, Yadagiri G, Singh A, Karole A, Singh O, Sundar S . Improvising anti-leishmanial activity of amphotericin B and paromomycin using co-delivery in d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) tailored nano-lipid carrier system. Chem Phys Lipids. 2020; 231:104946. DOI: 10.1016/j.chemphyslip.2020.104946. View

16.

Han L, Yang Q, Shen T, Qing J, Wang J . Lymphatic transport of orally administered probucol-loaded mPEG-DSPE micelles. Drug Deliv. 2015; 23(6):1955-61. DOI: 10.3109/10717544.2015.1028600. View

17.

Mohanty B, Majumdar D, Mishra S, Panda A, Patnaik S . Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery. Pharm Dev Technol. 2014; 20(4):458-64. DOI: 10.3109/10837450.2014.882935. View

18.

Hegazy H, M Amin M, Fayad W, Zakaria M . "TPGS surface modified bilosomes as boosting cytotoxic oral delivery systems of curcumin against doxorubicin resistant MCF-7 breast cancer cells". Int J Pharm. 2022; 619:121717. DOI: 10.1016/j.ijpharm.2022.121717. View

19.

Wu Y, Chu Q, Tan S, Zhuang X, Bao Y, Wu T . D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery. Int J Nanomedicine. 2015; 10:5219-35. PMC: 4548758. DOI: 10.2147/IJN.S82847. View

20.

Castro G, Coelho A, Oliveira C, Mahecha G, Orefice R, Ferreira L . Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. Int J Pharm. 2009; 381(1):77-83. DOI: 10.1016/j.ijpharm.2009.07.025. View